搜尋





搜尋





市場行情
/
股票
/
nasdaq-drts
/

Alpha Tau Medical Ltd

DRTS

添加自選

13.230USD

+0.590+4.67%

收盤 07/02, 13:00（美東）報價延遲15分鐘

1.19B總市值

虧損本益比TTM

Alpha Tau Medical Ltd

13.230

+0.590+4.67%

概覽

財務

分析

公司

查看詳細走勢圖

TradingKey 图表

盤中分時

1分

30分

1小時

日k

週k

月k

日k

今天

+4.67%

5天

+31.64%

1月

+36.89%

6月

+167.27%

今年開始到現在

+167.27%

1年

+324.04%

關鍵數據

12.730今開

13.230最高

1.15M成交量

虧損本益比TTM

虧損本益比動

--股利TTM

1.27%換手率

12.640昨收

12.390最低

11.05M成交額

虧損本益比靜

17.20市淨率

0.00%股息率 TTM

-44.44%ROA

11.62052週最高

1.85量比

-31.75M淨利潤

90.18M總股本

-0.6613每股盈餘TTM

1.16Beta

-90.51%ROE

2.81052週最低

6.65%振幅

--毛利率

1.19B總市值

4.55回報/風險

4.28%風險率

TradingKey 股票評分

由於缺少必要的數據，暫時無法對該公司進行評分

Alpha Tau Medical Ltd新聞

即將為您帶來更多新聞，敬請期待。。。

Alpha Tau Medical Ltd is an Israel-based medical technology company that focuses on research, development and commercialization of Alpha DaRT Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT) for the treatment of solid cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The Company has one subsidiary Healthcare Capital Corp.

公司代碼DRTS

公司Alpha Tau Medical Ltd

CEOSofer (Uzi)

網址https://www.alphatau.com/